|
US2065593A
(en)
|
|
1936-12-29 |
|
Water-soluble diazoimino com |
|
FR472489A
(fr)
|
1914-02-20 |
1914-12-08 |
Stas Motor Ges M B H |
Bague de garniture métallique pour pistons
|
|
US2065900A
(en)
|
1935-03-23 |
1936-12-29 |
Gen Aniline Works Inc |
Dihydroxystilbene-dicarboxylic acid and a process of preparing it
|
|
US2071329A
(en)
|
1935-08-22 |
1937-02-23 |
Solvay Process Co |
Method of recovering phthalic anhydride
|
|
GB728767A
(en)
|
1951-10-12 |
1955-04-27 |
Wander Ag Dr A |
2-substituted chromone compounds, and a method of making same
|
|
US3251837A
(en)
|
1962-09-14 |
1966-05-17 |
Pfizer & Co C |
Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
|
|
GB1179019A
(en)
|
1967-05-23 |
1970-01-28 |
Produits Chimique Soc Et |
Polynicotinic Esters of Flavonoids
|
|
FR6928M
(https=)
|
1967-11-24 |
1969-05-05 |
|
|
|
US3600394A
(en)
|
1968-05-17 |
1971-08-17 |
Searle & Co |
2-aminoalkyl-3-arylisocarbostyrils
|
|
US3773946A
(en)
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
|
US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
|
FR2244493A1
(en)
|
1973-08-09 |
1975-04-18 |
Pluripharm |
Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis
|
|
DE2349024A1
(de)
|
1973-09-26 |
1975-04-10 |
Schering Ag |
6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione
|
|
IT1050750B
(it)
|
1975-12-05 |
1981-03-20 |
Erba Carlo Spa |
Derivati della 3.4 di idro chinazolina
|
|
US4159330A
(en)
|
1976-11-02 |
1979-06-26 |
Carlo Erba S.P.A. |
2-Disubstituted phenyl-3,4-dihydro-4-oxo-quinazoline derivatives and process for their preparation
|
|
US5098903A
(en)
|
1980-03-07 |
1992-03-24 |
Board Of Regents Of The University Of Oklahoma |
Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents
|
|
IL64542A0
(en)
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
JPS60136512A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
|
DE3423166A1
(de)
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
CA1281720C
(en)
|
1984-11-08 |
1991-03-19 |
Makoto Sunagawa |
Carbapenem compounds and production thereof
|
|
DE3515882A1
(de)
|
1985-05-03 |
1986-11-06 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung
|
|
DE3532279A1
(de)
|
1985-09-11 |
1987-03-12 |
Bayer Ag |
1,4-benzoxathiin-derivate
|
|
DE3601417A1
(de)
|
1986-01-20 |
1987-07-23 |
Nattermann A & Cie |
2'-alkyl-(alkenyl-) substituierte quercetine
|
|
EP0258190B1
(de)
|
1986-08-29 |
1991-11-27 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von aromatischen Ether- und Thioetherverbindungen
|
|
EP0272455B1
(en)
|
1986-11-24 |
1993-02-10 |
Fujisawa Pharmaceutical Co., Ltd. |
3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds
|
|
GB8804058D0
(en)
|
1988-02-22 |
1988-03-23 |
Fujisawa Pharmaceutical Co |
3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
|
|
US4925838A
(en)
|
1988-03-18 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
US4963544A
(en)
|
1988-05-23 |
1990-10-16 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
GB8926981D0
(en)
|
1988-12-23 |
1990-01-17 |
Ici Plc |
Heterocyclic derivatives
|
|
WO1991000858A1
(en)
|
1989-07-07 |
1991-01-24 |
Schering Corporation |
Pharmaceutically active compounds
|
|
FR2649612A1
(fr)
|
1989-07-17 |
1991-01-18 |
Rhone Poulenc Sante |
Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation
|
|
IE64358B1
(en)
|
1989-07-18 |
1995-07-26 |
Ici Plc |
Diaryl ether heterocycles
|
|
GB9018134D0
(en)
|
1989-09-29 |
1990-10-03 |
Ici Plc |
Heterocyclic derivatives
|
|
ES2098357T3
(es)
|
1990-06-05 |
1997-05-01 |
Toray Industries |
Derivado de indol.
|
|
JP2999579B2
(ja)
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Ｄｎａおよびその用途
|
|
GB9025832D0
(en)
|
1990-11-28 |
1991-01-09 |
Ashwell Geoffrey J |
Novel films for nonlinear optical applications
|
|
IE913866A1
(en)
|
1990-11-28 |
1992-06-03 |
Ici Plc |
Aryl derivatives
|
|
US5126351A
(en)
|
1991-01-24 |
1992-06-30 |
Glaxo Inc. |
Antitumor compounds
|
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
|
WO1992018123A2
(en)
|
1991-04-10 |
1992-10-29 |
Octamer, Inc. |
A method for inhibition of retroviral replication
|
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5124337A
(en)
|
1991-05-20 |
1992-06-23 |
Schering Corporation |
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
|
|
US5223506A
(en)
|
1991-06-04 |
1993-06-29 |
Glaxo Inc. |
Cyclic antitumor compounds
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
|
GB9126260D0
(en)
|
1991-12-11 |
1992-02-12 |
Pfizer Ltd |
Therapeutic agents
|
|
US5474994A
(en)
|
1992-05-26 |
1995-12-12 |
Recordati S.A., Chemical And Pharmaceutical Company |
Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
|
|
FR2689127B1
(fr)
|
1992-03-31 |
1994-05-06 |
Adir Cie |
Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
|
|
US7655699B1
(en)
|
1992-04-22 |
2010-02-02 |
Eisai Inc. |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
DE4215587A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
|
|
DE4215588A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Biphenylmethyl-substituierte Pyridone
|
|
GB9218334D0
(en)
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
|
JPH0680656A
(ja)
|
1992-09-03 |
1994-03-22 |
Mitsui Petrochem Ind Ltd |
光学活性エポキシドの製造方法
|
|
WO1994014763A1
(en)
|
1992-12-23 |
1994-07-07 |
Procept, Inc. |
Novel agents for inhibition of hiv infectivity and use therefor
|
|
JPH0741442A
(ja)
|
1993-05-21 |
1995-02-10 |
Sumitomo Chem Co Ltd |
アセチレンアルコール誘導体およびその製造法
|
|
JPH0761942A
(ja)
|
1993-06-17 |
1995-03-07 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
|
JPH0725761A
(ja)
|
1993-07-09 |
1995-01-27 |
Kureha Chem Ind Co Ltd |
軟骨保護剤
|
|
EP0709373B1
(en)
|
1993-07-23 |
2001-10-17 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Pyrrolidine derivative
|
|
US5707547A
(en)
|
1993-08-03 |
1998-01-13 |
Sumitomo Chemical Company, Limited |
Trans-olefin compounds, method for production thereof, liquid crystal composition containing the same as active ingredient, and liquid crystal element using said composition
|
|
JPH07118241A
(ja)
|
1993-09-01 |
1995-05-09 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
|
JPH07179380A
(ja)
|
1993-12-22 |
1995-07-18 |
Sumitomo Chem Co Ltd |
アルコール誘導体およびその製造法
|
|
JPH07233109A
(ja)
|
1994-02-24 |
1995-09-05 |
Sumitomo Chem Co Ltd |
光学活性なアルコール誘導体およびその製造法
|
|
EP0747381B1
(en)
|
1994-02-25 |
2001-10-31 |
Banyu Pharmaceutical Co., Ltd. |
Carbapenem derivative
|
|
EP0749974B1
(en)
|
1994-03-08 |
2001-06-27 |
Otsuka Pharmaceutical Factory, Inc. |
Phosphonic diester derivative
|
|
JPH07247289A
(ja)
|
1994-03-11 |
1995-09-26 |
Mitsui Petrochem Ind Ltd |
クロメンオキシド類の製造方法
|
|
FR2718329B1
(fr)
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
|
US6048903A
(en)
|
1994-05-03 |
2000-04-11 |
Robert Toppo |
Treatment for blood cholesterol with trans-resveratrol
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
GB2292149A
(en)
|
1994-08-09 |
1996-02-14 |
Ferring Res Ltd |
Peptide inhibitors of pro-interleukin-1beta converting enzyme
|
|
JP3702493B2
(ja)
|
1994-08-12 |
2005-10-05 |
大正製薬株式会社 |
キナゾリン−４（３ｈ）−オン誘導体
|
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
|
PL181893B1
(pl)
|
1994-11-14 |
2001-10-31 |
Warner Lambert Co |
Zwiazki bedace pochodnymi pirymidyny i naftyrydyny oraz preparat farmaceutyczny zawierajacy je PL PL PL
|
|
US5446071A
(en)
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
|
JP4140981B2
(ja)
|
1994-12-26 |
2008-08-27 |
東菱薬品工業株式会社 |
再狭窄症及び動脈硬化症治療薬
|
|
US5648387A
(en)
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
|
WO1996031206A2
(en)
|
1995-04-07 |
1996-10-10 |
Warner-Lambert Company |
Flavones and coumarins as agents for the treatment of atherosclerosis
|
|
EP0747051B1
(en)
|
1995-06-07 |
2002-07-24 |
Eli Lilly And Company |
Treatment of diseases by inducing BEF-1 transcription factor
|
|
US5922866A
(en)
|
1995-08-30 |
1999-07-13 |
Otsuka Pharmaceutical Factory, Inc. |
Process for preparing quinazolin-4-one derivatives
|
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
|
AU4858596A
(en)
|
1995-09-15 |
1997-04-01 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
|
KR19990067010A
(ko)
|
1995-10-23 |
1999-08-16 |
오스테오스크린, 인코포레이티드 |
골결핍 상태의 치료용 조성물 및 그 치료방법
|
|
RU2135494C1
(ru)
|
1995-12-01 |
1999-08-27 |
Санкио Компани Лимитед |
Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
|
|
US5756736A
(en)
|
1996-01-26 |
1998-05-26 |
Syntex (U.S.A.) Inc. |
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
|
|
WO1997028118A1
(en)
|
1996-02-05 |
1997-08-07 |
Hoechst Celanese Corporation |
Process for preparing anthranilic acids
|
|
US5739330A
(en)
|
1996-02-05 |
1998-04-14 |
Hoechst Celanese Corporation |
Process for preparing quinazolones
|
|
US5763608A
(en)
|
1996-02-05 |
1998-06-09 |
Hoechst Celanese Corporation |
Process for preparing pyrimidine derivatives
|
|
CA2241551A1
(en)
|
1996-02-12 |
1997-08-14 |
Rutgers, The State University Of New Jersey |
Coralyne analogs as topoisomerase inhibitors
|
|
WO1997048694A1
(en)
|
1996-06-20 |
1997-12-24 |
Board Of Regents, The University Of Texas System |
Compounds and methods for providing pharmacologically active preparations and uses thereof
|
|
US5854264A
(en)
|
1996-07-24 |
1998-12-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
KR100213895B1
(ko)
|
1996-10-14 |
1999-08-02 |
박원훈 |
감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
|
|
DE19651099A1
(de)
|
1996-12-09 |
1998-06-10 |
Consortium Elektrochem Ind |
Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
|
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
|
JPH10287678A
(ja)
|
1997-04-11 |
1998-10-27 |
Kyowa Hakko Kogyo Co Ltd |
ピラノアジン誘導体
|
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
|
AU7484798A
(en)
|
1997-05-13 |
1998-12-08 |
Octamer, Inc. |
Methods for treating inflammation, inflammatory diseases, arthritis and strok e using padprt inhibitors
|
|
AU740603B2
(en)
|
1997-06-02 |
2001-11-08 |
Janssen Pharmaceutica N.V. |
(imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
|
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
|
CN1159302C
(zh)
|
1997-08-29 |
2004-07-28 |
武田舍林-普劳动物保健株式会社 |
三嗪衍生物,其制备及应用
|
|
US20020022636A1
(en)
|
1997-09-03 |
2002-02-21 |
Jia-He Li |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
|
US6239114B1
(en)
|
1997-09-26 |
2001-05-29 |
Kgk Synergize |
Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
|
|
ATE404539T1
(de)
|
1997-10-02 |
2008-08-15 |
Eisai R&D Man Co Ltd |
Kondensierte pyridinderivate
|
|
JP2001520992A
(ja)
|
1997-10-28 |
2001-11-06 |
コリア インスティテュート オブ サイエンス アンド テクノロジー |
アシルｃｏａ−コレステロール−ｏ−アシルトランスフェラーゼ抑制剤、動脈壁上でのマクロファージ−脂質複合体蓄積の抑制剤および肝疾患予防または治療剤としてのナリンジンおよびナリンゲニン
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
DE19756388A1
(de)
|
1997-12-18 |
1999-06-24 |
Hoechst Marion Roussel De Gmbh |
Substituierte 2-Aryl-4-amino-chinazoline
|
|
EP1049767B1
(en)
|
1998-01-08 |
2005-08-17 |
Aventis Pharmaceuticals Inc. |
A transgenic rabbit that expresses a functional human lipoprotein (a)
|
|
US6414037B1
(en)
|
1998-01-09 |
2002-07-02 |
Pharmascience |
Pharmaceutical formulations of resveratrol and methods of use thereof
|
|
CN100374159C
(zh)
|
1998-03-17 |
2008-03-12 |
中外制药株式会社 |
一种包含il-6拮抗剂活性成分的炎性肠道疾病的预防或治疗剂
|
|
US6022901A
(en)
|
1998-05-13 |
2000-02-08 |
Pharmascience Inc. |
Administration of resveratrol to prevent or treat restenosis following coronary intervention
|
|
ES2276525T3
(es)
|
1998-08-24 |
2007-06-16 |
Chugai Seiyaku Kabushiki Kaisha |
Preventivos o remedios para la pancreatitis que contienen anticuerpos anti-receptor il-6 como ingrediente activo.
|
|
SE9802973D0
(sv)
|
1998-09-03 |
1998-09-03 |
Astra Ab |
Immediate release tablet
|
|
EP1115718A1
(en)
|
1998-09-24 |
2001-07-18 |
Mitsubishi Chemical Corporation |
Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
|
|
CA2345406A1
(en)
|
1998-10-19 |
2000-04-27 |
Eisai Co., Ltd. |
Analgesic
|
|
WO2000023073A1
(en)
|
1998-10-20 |
2000-04-27 |
Korea Institute Of Science And Technology |
Bioflavonoids as plasma high density lipoprotein level increasing agent
|
|
AU2190700A
(en)
|
1998-12-17 |
2000-07-03 |
Tularik Inc. |
Tubulin-binding agents
|
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
US6399633B1
(en)
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
|
KR20020008127A
(ko)
|
1999-03-15 |
2002-01-29 |
스티븐 에프. 웨인스톡 |
항균 활성을 갖는 6-ｏ-치환된 매크롤라이드
|
|
US6969720B2
(en)
|
1999-03-17 |
2005-11-29 |
Amr Technology, Inc. |
Biaryl substituted purine derivatives as potent antiproliferative agents
|
|
US6054435A
(en)
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
|
US6835755B1
(en)
|
1999-06-24 |
2004-12-28 |
University Of Pretoria |
Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
|
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
|
JP2001131151A
(ja)
|
1999-11-02 |
2001-05-15 |
Shionogi & Co Ltd |
オレフィン誘導体の新規用途
|
|
JP5278983B2
(ja)
|
1999-11-17 |
2013-09-04 |
塩野義製薬株式会社 |
アミド化合物の新規用途
|
|
WO2001042231A2
(en)
|
1999-12-06 |
2001-06-14 |
Welichem Biotech Inc. |
Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
|
|
FR2804679B1
(fr)
|
2000-02-07 |
2002-04-26 |
Clariant France Sa |
Nouveaux composes phenoliques derives des dialcoxyethanals, leur procede de preparation et leur application
|
|
JP2003522810A
(ja)
|
2000-02-17 |
2003-07-29 |
アップルトン ペーパーズ インコーポレイテッド |
アルコキシ又はアリルメトキシエタンの製造方法
|
|
KR100774855B1
(ko)
|
2000-04-27 |
2007-11-08 |
아스텔라스세이야쿠 가부시키가이샤 |
축합 헤테로아릴 유도체
|
|
AU6118001A
(en)
|
2000-05-03 |
2001-11-12 |
Tularik Inc |
Combination therapeutic compositions and methods of use
|
|
US6548694B2
(en)
|
2000-05-23 |
2003-04-15 |
Hoffman-La Roche Inc. |
N-(4-carbamimidoyl-phenyl)-glycine derivatives
|
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
|
US6479499B1
(en)
|
2000-06-28 |
2002-11-12 |
National Science Council |
2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
|
|
US20020025301A1
(en)
|
2000-07-04 |
2002-02-28 |
Sylke Haremza |
Novel flavonoids and their use in cosmetic and dermatological preparations
|
|
US6541522B2
(en)
|
2000-08-16 |
2003-04-01 |
Insmed Incorporated |
Methods of using compositions containing hypotriglyceridemically active stilbenoids
|
|
US7723303B2
(en)
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
CA2424300A1
(en)
|
2000-10-02 |
2002-04-11 |
Molecular Probes, Inc. |
Reagents for labeling biomolecules having aldehyde or ketone moieties
|
|
CA2356544C
(en)
|
2000-10-03 |
2006-04-04 |
Warner-Lambert Company |
Pyridotriazines and pyridopyridazines
|
|
CN1478077A
(zh)
|
2000-10-05 |
2004-02-25 |
����ҩƷ��ҵ��ʽ���� |
作为apo b分泌抑制剂的苯甲酰胺化合物
|
|
CN101426763A
(zh)
|
2000-10-11 |
2009-05-06 |
埃斯佩里安医疗公司 |
用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物
|
|
JP2004531459A
(ja)
|
2000-10-11 |
2004-10-14 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロールマネージメント用スルホキシドおよびビススルホキシド化合物ならびに組成物および関連する使用
|
|
IL154984A0
(en)
|
2000-10-19 |
2003-10-31 |
Merck & Co Inc |
Estrogen receptor modulators
|
|
EP1889891B1
(en)
|
2000-11-30 |
2017-11-22 |
Canon Kabushiki Kaisha |
Luminescence device and display apparatus
|
|
CN1486302A
(zh)
|
2000-12-07 |
2004-03-31 |
CV���ƹ�˾ |
作为抗冠状动脉疾病或动脉硬化的abca-1加强化合物的取代1,3,5-三嗪和嘧啶
|
|
KR100472694B1
(ko)
|
2000-12-30 |
2005-03-07 |
한국생명공학연구원 |
플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
|
|
JP2002249483A
(ja)
|
2001-02-21 |
2002-09-06 |
Koei Chem Co Ltd |
アリール置換複素環式化合物の製造法
|
|
JP4256679B2
(ja)
|
2001-03-16 |
2009-04-22 |
ノボゲン リサーチ ピーティーワイ リミテッド |
再狭窄の治療方法
|
|
US20030064967A1
(en)
|
2001-04-11 |
2003-04-03 |
Jayraz Luchoomun |
Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters
|
|
CA2447475A1
(en)
|
2001-05-25 |
2002-12-05 |
Chu-Biao Xue |
Hydantion derivatives as inhibitors of matrix metalloproteinases
|
|
US20030211086A1
(en)
*
|
2001-06-05 |
2003-11-13 |
Neil Berkley |
Minicell-based selective absorption
|
|
WO2003007959A1
(en)
|
2001-07-16 |
2003-01-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoxaline derivatives which have parp inhibitory action
|
|
GB0118752D0
(en)
|
2001-08-01 |
2001-09-26 |
Pfizer Ltd |
Process for the production of quinazolines
|
|
JP2005504047A
(ja)
|
2001-08-13 |
2005-02-10 |
チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド |
紫外線吸収剤
|
|
US20040248950A1
(en)
|
2001-08-24 |
2004-12-09 |
Natsuki Ishizuka |
Apo ai expression accelerating agent
|
|
EP2168576A3
(en)
|
2001-09-14 |
2010-05-26 |
Shionogi & Co., Ltd. |
Tricyclic compounds for treating dyslipidemia and arteriosclerotic diseases
|
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
|
US6835469B2
(en)
|
2001-10-17 |
2004-12-28 |
The University Of Southern California |
Phosphorescent compounds and devices comprising the same
|
|
US7250512B2
(en)
|
2001-11-07 |
2007-07-31 |
E. I. Du Pont De Nemours And Company |
Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
|
|
US7166368B2
(en)
|
2001-11-07 |
2007-01-23 |
E. I. Du Pont De Nemours And Company |
Electroluminescent platinum compounds and devices made with such compounds
|
|
US6541045B1
(en)
|
2002-01-04 |
2003-04-01 |
Nutraceutical Corporation |
Herbal composition and method for combating inflammation
|
|
WO2003064399A1
(fr)
|
2002-01-28 |
2003-08-07 |
Ube Industries, Ltd. |
Procede de production de derive de quinazolin-4-one
|
|
US20050176796A1
(en)
|
2002-02-19 |
2005-08-11 |
D'alessio Roberto |
Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
|
|
GB0206033D0
(en)
|
2002-03-14 |
2002-04-24 |
Pfizer Ltd |
Compounds useful in therapy
|
|
NZ556545A
(en)
|
2002-03-22 |
2009-03-31 |
Novartis Ag |
Combination comprising a beta-hydroxy-beta-methylglutaryl-co-enzyme-A reductase inhibitor and a glucagon-like peptide-1 agonist
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
TW200401770A
(en)
|
2002-06-18 |
2004-02-01 |
Sankyo Co |
Fused-ring pyrimidin-4(3H)-one derivatives, processes for the preparation and uses thereof
|
|
KR20040001144A
(ko)
|
2002-06-27 |
2004-01-07 |
김대경 |
신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
|
|
US20050080024A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
|
US20040033480A1
(en)
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
|
US20050080021A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
|
EP1542948A4
(en)
|
2002-08-23 |
2008-12-17 |
Univ Connecticut |
NEW BIPHENYL AND BIPHENYLENE CANNABINOIDS
|
|
AU2003262946A1
(en)
|
2002-08-30 |
2004-03-19 |
Pharmacia And Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
|
EP1398032A1
(en)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
EP1407774A1
(en)
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
AU2003284001A1
(en)
|
2002-10-07 |
2004-05-04 |
Bristol-Myers Squibb Company |
Triazolone and triazolethione derivatives
|
|
WO2004037176A2
(en)
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
|
MXPA05004328A
(es)
|
2002-11-04 |
2005-08-02 |
Nps Pharma Inc |
Compuestos de quinazolinona como calciliticos.
|
|
EP1418164A1
(en)
|
2002-11-07 |
2004-05-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
|
|
KR20050075028A
(ko)
|
2002-11-18 |
2005-07-19 |
에프. 호프만-라 로슈 아게 |
다이아지노피리미딘
|
|
RU2342388C2
(ru)
|
2002-11-22 |
2008-12-27 |
Джапан Тобакко Инк. |
Конденсированные бициклические азотсодержащие гетероциклы, обладающие dgat ингибирующим действием
|
|
JP4384053B2
(ja)
|
2002-12-13 |
2009-12-16 |
エフ．ホフマン−ラ ロシュ アーゲー |
３ｈ−キナゾリン−４−オン誘導体
|
|
ITRM20020629A1
(it)
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
|
WO2004058717A1
(en)
|
2002-12-20 |
2004-07-15 |
X-Ceptor Therapeutics, Inc. |
Isoquinolinone derivatives and their use as therapeutic agents
|
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換６，６−ヘテロ二環式誘導体
|
|
CA2512000C
(en)
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
|
WO2004072042A2
(en)
|
2003-02-12 |
2004-08-26 |
Carex S.A. |
Quinoline derivative and their use for modulation of lxr activity
|
|
AU2004230841A1
(en)
|
2003-04-03 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
JP4895806B2
(ja)
|
2003-04-09 |
2012-03-14 |
エクセリクシス， インク． |
Ｔｉｅ−２モジュレータと使用方法
|
|
JP2004307440A
(ja)
|
2003-04-10 |
2004-11-04 |
Kyorin Pharmaceut Co Ltd |
２−アミノ‐１，３‐プロパンジオール誘導体とその付加塩
|
|
JP4733023B2
(ja)
|
2003-04-16 |
2011-07-27 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ型肝炎ウイルスの大環状イソキノリンペプチド阻害剤
|
|
SI1631295T1
(sl)
|
2003-06-06 |
2010-06-30 |
Arexis Ab |
Uporaba kondenziranih heterocikličnih spojin kotSCCE inhibitorjev za zdravljenje kožnih bolezni
|
|
ES2389258T3
(es)
|
2003-06-17 |
2012-10-24 |
Millennium Pharmaceuticals, Inc. |
Composiciones y métodos para inhibir TGF-s
|
|
WO2004113307A1
(ja)
|
2003-06-18 |
2004-12-29 |
Ube Industries, Ltd. |
ピリミジン−４−オン化合物の製造方法
|
|
US20050043300A1
(en)
|
2003-08-14 |
2005-02-24 |
Pfizer Inc. |
Piperazine derivatives
|
|
JP2007509035A
(ja)
|
2003-10-10 |
2007-04-12 |
レスバーロジックス コーポレイション |
Ｅｇｒ−１エンハンサー要素に関連する疾患の処置
|
|
US20050096391A1
(en)
|
2003-10-10 |
2005-05-05 |
Per Holm |
Compositions comprising fenofibrate and rosuvastatin
|
|
RU2006112343A
(ru)
|
2003-10-28 |
2007-12-10 |
Редди Юс Терапеутикс, Инк. (Us) |
Гетероциклические соединения и способы их получения и применения
|
|
CA2549641A1
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
WO2005066162A1
(en)
|
2003-12-23 |
2005-07-21 |
Human Biomolecular Research Institute |
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
|
|
TW200536830A
(en)
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
|
JPWO2005115993A1
(ja)
|
2004-05-31 |
2008-03-27 |
萬有製薬株式会社 |
キナゾリン誘導体
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
WO2006012577A2
(en)
|
2004-07-22 |
2006-02-02 |
Bayer Pharmaceuticals Corporation |
Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
|
|
US20070218155A1
(en)
|
2004-08-20 |
2007-09-20 |
Kuhrts Eric H |
Methods and compositions for treating dyslipidaemia
|
|
WO2006045010A2
(en)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
KR20060079121A
(ko)
|
2004-12-31 |
2006-07-05 |
에스케이케미칼주식회사 |
당뇨 및 비만 치료예방에 유효한 퀴나졸린 유도체
|
|
CR9465A
(es)
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
|
US20070004763A1
(en)
*
|
2005-06-10 |
2007-01-04 |
Nand Baindur |
Aminoquinoline and aminoquinazoline kinase modulators
|
|
US8410109B2
(en)
|
2005-07-29 |
2013-04-02 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
EP1944301A4
(en)
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
KR20080089416A
(ko)
|
2005-12-21 |
2008-10-06 |
페인셉터 파마 코포레이션 |
개폐 이온 통로를 조절하기 위한 조성물 및 방법
|
|
EP1928425B1
(en)
|
2006-05-12 |
2013-01-23 |
Pharmathen S.A. |
Pharmaceutical formulation containing fluvastatin
|
|
EP2079448A2
(en)
|
2006-10-10 |
2009-07-22 |
Dexcel Pharma Technologies Ltd. |
Improved release of statins in the intestine
|
|
US20080085911A1
(en)
|
2006-10-10 |
2008-04-10 |
Reliant Pharmaceuticals, Inc. |
Statin and omega-3 fatty acids for reduction of apo-b levels
|
|
EP2097391A1
(en)
|
2006-11-15 |
2009-09-09 |
High Point Pharmaceuticals, LLC |
2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
|
|
US8377875B2
(en)
*
|
2007-01-11 |
2013-02-19 |
Ramot At Tel-Aviv University Ltd. |
Therapeutics based on tau/microtubule dynamics
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
ES2308916B1
(es)
|
2007-03-22 |
2009-10-29 |
Consejo Superior De Investigaciones Cientificas |
Compuesto inhibidor dual de las enzimas pde7 y/o pde4, composiciones farmaceuticas y sus aplicaciones.
|
|
EP2005941A3
(de)
|
2007-06-01 |
2009-04-01 |
Henkel AG & Co. KGaA |
Zellverjüngende Zusammensetzungen
|
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
|
WO2008157575A1
(en)
|
2007-06-21 |
2008-12-24 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
KR101600634B1
(ko)
|
2007-12-28 |
2016-03-07 |
미쓰비시 타나베 파마 코퍼레이션 |
항암제
|
|
SI2346837T1
(sl)
|
2008-06-26 |
2015-05-29 |
Resverlogix Corporation |
Postopki pripravljanja kinazolinonskih derivatov
|
|
US20110201608A1
(en)
|
2008-08-05 |
2011-08-18 |
Boehringer Ingelheim International Gmbh |
Substituted naphthyridines and use thereof as medicines
|
|
CA2737924A1
(en)
|
2008-10-06 |
2010-04-15 |
Joshua Robert Schultz |
Methods of treating inflammation
|
|
ES2448567T3
(es)
|
2008-10-30 |
2014-03-14 |
Circomed Llc |
Derivados de la tienotriazoldiazepina activos en apo A
|
|
WO2010056910A2
(en)
|
2008-11-12 |
2010-05-20 |
Carolus Therapeutics, Inc. |
Methods of treating cardiovascular disorders
|
|
US8952021B2
(en)
|
2009-01-08 |
2015-02-10 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
|
MX2011008641A
(es)
|
2009-03-06 |
2011-09-06 |
Hoffmann La Roche |
Compuestos heterociclicos antivirales.
|
|
KR101913109B1
(ko)
|
2009-03-18 |
2018-10-31 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
US9757368B2
(en)
*
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|
|
SG175390A1
(en)
|
2009-04-29 |
2011-12-29 |
Amarin Corp Plc |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
|
ES2353093B1
(es)
|
2009-05-20 |
2012-01-03 |
Consejo Superior De Investigaciones Científicas (Csic) |
Uso de derivados de quinazolinas y sus composiciones farmacéuticas en enfermedades neurodegenerativas.
|
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
|
DE102010048800A1
(de)
|
2010-10-20 |
2012-05-10 |
Merck Patent Gmbh |
Chinoxalinderivate
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
UA109797C2
(uk)
|
2010-11-05 |
2015-10-12 |
|
Спосіб боротьби з бур'янами, що мають стійкість до гербіцидів на основі феноксіалканових кислот, за допомогою 4-аміно-3-хлор-6-(4-хлор-2-фтор-3-метоксифеніл)піридин-2-карбонової кислоти і її солей або складних ефірів
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
WO2012112531A1
(en)
|
2011-02-16 |
2012-08-23 |
Pivotal Therapeutics, Inc. |
Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
|
|
WO2012174487A2
(en)
|
2011-06-17 |
2012-12-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
CN103842364A
(zh)
|
2011-09-30 |
2014-06-04 |
奇尼塔公司 |
抗病毒化合物
|
|
CA2851996C
(en)
*
|
2011-11-01 |
2020-01-07 |
Resverlogix Corp. |
Pharmaceutical compositions for substituted quinazolinones
|
|
US20130281398A1
(en)
*
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
PT2906531T
(pt)
|
2012-10-15 |
2018-02-06 |
Resverlogix Corp |
Compostos úteis na síntese de compostos de benzamida
|
|
KR101991148B1
(ko)
|
2012-10-15 |
2019-06-19 |
알베마를 코포레이션 |
2-아미노-4,6-디메톡시벤즈아미드 및 기타 벤즈아미드 화합물의 합성 방법
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
US9765039B2
(en)
*
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
US20150352189A1
(en)
|
2013-01-08 |
2015-12-10 |
Jerome Schentag |
Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems
|
|
JP2016510039A
(ja)
|
2013-02-28 |
2016-04-04 |
ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ |
ブロモドメイン阻害剤によるヒトサイトメガロウイルス感染および疾患の治療方法
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
EA201591746A1
(ru)
|
2013-03-14 |
2016-08-31 |
КОНВЕРДЖЕН ЭлЭлСи |
Способы и композиции для ингибирования бромодомен-содержащих белков
|
|
SI2978859T1
(sl)
|
2013-03-27 |
2018-10-30 |
F. Hoffmann-La Roche Ag |
Genetski označevalci za napovedovanje odzivnosti na terapijo
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
HK1219434A1
(zh)
|
2013-08-21 |
2017-04-07 |
Resverlogix Corp. |
用於加速斑块消退的组合物和治疗方法
|
|
AU2014310371A1
(en)
*
|
2013-08-21 |
2016-03-10 |
Resverlogix Corp. |
Compositions and therapeutic methods for accelerated plaque regression
|
|
US9814728B2
(en)
|
2013-09-20 |
2017-11-14 |
Saint Louis University |
Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi)
|
|
EP3689420A1
(en)
|
2014-01-23 |
2020-08-05 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Icariin derivatives for use in treating myelodysplasia syndrome
|
|
MX384679B
(es)
|
2014-07-30 |
2025-03-14 |
Hoffmann La Roche |
Marcadores genéticos para predecir la reactividad a terapia con agente que eleva la lipoproteína de alta densidad (hdl) o que imita la lipoproteína de alta densidad (hdl).
|
|
WO2016123054A2
(en)
|
2015-01-26 |
2016-08-04 |
The University Of North Carolina At Chapel Hill |
Kinase drug combinations and methods of use thereof
|
|
US20180104232A1
(en)
|
2015-03-12 |
2018-04-19 |
The University Of Chicago |
Methods for determining prognosis for breast cancer patients
|
|
US10111885B2
(en)
|
2015-03-13 |
2018-10-30 |
Resverlogix Corp. |
Compositions and therapeutic methods for the treatment of complement-associated diseases
|
|
RU2017142394A
(ru)
|
2015-05-08 |
2019-06-10 |
Президент Энд Феллоус Оф Гарвард Колледж |
Целевой отбор пациентов для лечения производными кортистатина
|
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
CN106265679A
(zh)
|
2015-06-28 |
2017-01-04 |
复旦大学 |
溴结构域蛋白抑制剂在制备抗hiv-1潜伏治疗药物中的用途
|
|
US9896663B2
(en)
|
2016-03-11 |
2018-02-20 |
Peter Maccallum Cancer Institute |
Leukaemia stem cell line, its method of production and uses thereof
|
|
CN106176753A
(zh)
|
2016-07-15 |
2016-12-07 |
南方医科大学 |
Rvx‑208作为hiv‑1潜伏感染逆转剂的应用
|
|
US10158038B1
(en)
*
|
2018-05-17 |
2018-12-18 |
Hi Llc |
Fast-gated photodetector architectures comprising dual voltage sources with a switch configuration
|